Vietnamese pharmaceutical exports in 2025
2025 recorded many positive signs of Vietnam's pharmaceutical industry when drug and pharmaceutical raw material export activities continued to grow steadily, affirming production capacity, product quality and increasingly clear position in the international market. With correct orientation and synchronous reform solutions, the pharmaceutical industry is gradually moving towards the goal of sustainable development, proactive supply and increasing domestic market share.
According to aggregated data, in 2025, the total export value of drugs and pharmaceutical raw materials of Vietnam is estimated at about 312 million USD, with the participation of 67 enterprises. In which, foreign direct investment (FDI) enterprises continue to play a key role when contributing about 230 million USD, accounting for 75% of total export turnover. Domestic enterprises reached about 82 million USD, equivalent to 25%.
Regarding the market, Vietnamese pharmaceutical products are mainly exported to Asia, followed by Europe and Japan. These are all markets with high requirements for quality standards, showing that the competitiveness and level of meeting international standards of Vietnam's pharmaceutical industry are increasingly improved.
Domestic production capacity is increasingly perfected
Not only increasing exports, the domestic pharmaceutical industry has also made clear progress in production capacity and quality. Currently, Vietnam has fully produced 13/13 essential drug groups according to the classification of the World Health Organization (WHO), basically meeting domestic healthcare needs.
The whole country has 243 factories producing drugs meeting GMP-WHO standards, of which 29 factories meet higher standards such as EU-GMP or PIC/S-GMP. In addition, the pharmaceutical industry has gradually mastered the technology of producing some biological and pharmaceutical chemical materials, contributing to gradually reducing dependence on imports.
Quality management continues to be tightened. In 2025, the rate of fake drugs detected was only 0.024%, while the rate of substandard drugs was about 0.60%. These figures reflect the effectiveness of measures to control, inspect and supervise the pharmaceutical market.
In the coming time, the pharmaceutical industry aims to further enhance the role of domestically produced drugs. According to the orientation, domestic drugs strive to reach about 75% in quantity and 60% in value in the domestic market. This is considered an important foundation to ensure health security and proactive drug supply, especially in the context of a volatile international market.
In parallel with that, administrative procedure reform is identified as one of the key solutions. Reducing and simplifying procedures, promoting digital transformation and perfecting pharmaceutical industry development policies will create more favorable conditions for businesses to invest, expand production and improve competitiveness.
The pharmaceutical industry also focuses on ensuring the supply of rare drugs and drugs with limited supply, contributing to promptly meeting the treatment needs of people.
With an increasingly solid production foundation, strictly controlled quality and clear development orientations, Vietnam's pharmaceutical industry is expected to continue to break through in the coming years, both expanding exports and better meeting domestic needs, making positive contributions to socio-economic development and community health care.
